121 related articles for article (PubMed ID: 35605669)
1. Characterization of an immune-evading doxycycline-inducible lentiviral vector for gene therapy in the spinal cord.
De Winter F; Quijorna IF; Burnside E; Hobo B; Eggers R; Hoyng SA; Mulder HP; Hoeben RC; Muir EM; Bradbury EJ; Verhaagen J
Exp Neurol; 2022 Sep; 355():114120. PubMed ID: 35605669
[TBL] [Abstract][Full Text] [Related]
2. Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve.
Hoyng SA; Gnavi S; de Winter F; Eggers R; Ozawa T; Zaldumbide A; Hoeben RC; Malessy MJ; Verhaagen J
Gene Ther; 2014 Jun; 21(6):549-57. PubMed ID: 24694534
[TBL] [Abstract][Full Text] [Related]
3. Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in rats.
Markusic DM; de Waart DR; Seppen J
PLoS One; 2010 Apr; 5(4):e9974. PubMed ID: 20376311
[TBL] [Abstract][Full Text] [Related]
4. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system.
Ginhoux F; Turbant S; Gross DA; Poupiot J; Marais T; Lone Y; Lemonnier FA; Firat H; Perez N; Danos O; Davoust J
Mol Ther; 2004 Aug; 10(2):279-89. PubMed ID: 15294175
[TBL] [Abstract][Full Text] [Related]
5. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
Yang T; Burrows C; Park JH
Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
[TBL] [Abstract][Full Text] [Related]
6. Regulation of human factor IX expression using doxycycline-inducible gene expression system.
Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R
Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a Tet-On (rtTA-M2) transgenic rat.
Sheng Y; Lin CC; Yue J; Sukhwani M; Shuttleworth JJ; Chu T; Orwig KE
BMC Dev Biol; 2010 Feb; 10():17. PubMed ID: 20158911
[TBL] [Abstract][Full Text] [Related]
8. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter.
Markusic D; Oude-Elferink R; Das AT; Berkhout B; Seppen J
Nucleic Acids Res; 2005 Apr; 33(6):e63. PubMed ID: 15809225
[TBL] [Abstract][Full Text] [Related]
9. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.
Favre D; Blouin V; Provost N; Spisek R; Porrot F; Bohl D; Marmé F; Chérel Y; Salvetti A; Hurtrel B; Heard JM; Rivière Y; Moullier P
J Virol; 2002 Nov; 76(22):11605-11. PubMed ID: 12388721
[TBL] [Abstract][Full Text] [Related]
10. Two types of transgenic lines for doxycycline-inducible, cell-specific gene expression in zebrafish ultraviolet cone photoreceptors.
West MC; Campbell LJ; Willoughby JJ; Jensen AM
Gene Expr Patterns; 2014 Mar; 14(2):96-104. PubMed ID: 24462722
[TBL] [Abstract][Full Text] [Related]
11. Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines.
Benabdellah K; Cobo M; Muñoz P; Toscano MG; Martin F
PLoS One; 2011; 6(8):e23734. PubMed ID: 21876765
[TBL] [Abstract][Full Text] [Related]
12. A system for inducible gene expression in retinal ganglion cells.
Kerrison JB; Duh EJ; Yu Y; Otteson DC; Zack DJ
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2932-9. PubMed ID: 16043868
[TBL] [Abstract][Full Text] [Related]
13. Depot formation of doxycycline impairs Tet-regulated gene expression in vivo.
Anders K; Buschow C; Charo J; Blankenstein T
Transgenic Res; 2012 Oct; 21(5):1099-107. PubMed ID: 22167485
[TBL] [Abstract][Full Text] [Related]
14. Single-Construct Polycistronic Doxycycline-Inducible Vectors Improve Direct Cardiac Reprogramming and Can Be Used to Identify the Critical Timing of Transgene Expression.
Umei TC; Yamakawa H; Muraoka N; Sadahiro T; Isomi M; Haginiwa S; Kojima H; Kurotsu S; Tamura F; Osakabe R; Tani H; Nara K; Miyoshi H; Fukuda K; Ieda M
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825623
[TBL] [Abstract][Full Text] [Related]
15. Construction of a doxycycline inducible adipogenic lentiviral expression system.
Liu Q; Hill PJ; Karamitri A; Ryan KJ; Chen HY; Lomax MA
Plasmid; 2013 Jan; 69(1):96-103. PubMed ID: 23099229
[TBL] [Abstract][Full Text] [Related]
16. Generation of
Li YS; Meng RR; Chen X; Shang CL; Li HB; Zhang TJ; Long HY; Li HQ; Wang YJ; Wang FC
G3 (Bethesda); 2019 Feb; 9(2):591-599. PubMed ID: 30591434
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline- and tetracycline-regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA.
Lai JF; Cheng HY; Cheng TL; Lin YY; Chen LC; Lin MT; Jou TS
J Gene Med; 2004 Dec; 6(12):1403-13. PubMed ID: 15523716
[TBL] [Abstract][Full Text] [Related]
18. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
19. Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators.
Lamartina S; Roscilli G; Rinaudo CD; Sporeno E; Silvi L; Hillen W; Bujard H; Cortese R; Ciliberto G; Toniatti C
Hum Gene Ther; 2002 Jan; 13(2):199-210. PubMed ID: 11812277
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a transgenic zebrafish expressing the reverse tetracycline transactivator.
Gu Q; Yang X; He X; Li Q; Cui Z
J Genet Genomics; 2013 Oct; 40(10):523-31. PubMed ID: 24156918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
